RT - Journal Article T1 - Medical and Pharmaceutical Challenges of Globalization of Intellectual Property Rights JF - MLJ YR - 2007 JO - MLJ VO - 1 IS - 2 UR - http://ijmedicallaw.ir/article-1-668-en.html SP - 125 EP - 142 K1 - Drug Industry K1 - Intellectual Property K1 - Globalization K1 - Pharmaceutical Patents AB - Intellectual property plays an increasingly vital role in pharmaceutical and medical trade and development. Globalization of intellectual property rights means that pharmaceutical inventions are now protected anywhere and everywhere defying jurisdictional borders. Intellectual property has moved into the mainstream of national economic and developmental planning of pharmaceutical industry. In the recent years, it has also emerged as a central element of multilateral medical relations. It is probably more accurate to portray pharmaceutical and medical inventions as a class of intangible business asset that is usually held by global companies such as pharmaceutical companies performing the (admittedly important) roles in the modern economy of investors, employers, distributors and marketers. By globalization of intellectual property law, Individual pharmacologists are less frequently the ones who own and control the rights. Viewed in isolation, globalization of intellectual property law is a stunning triumph of the pharmaceutical companies in making global IP rules and in enlisting states and international organizations to enforce them. However, one must be careful not to generalize from one case. LA eng UL http://ijmedicallaw.ir/article-1-668-en.html M3 ER -